Publicacións (50) Publicacións de Ana Rita Santos Simoes

2023

  1. Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study

    Eye (Basingstoke), Vol. 37, Núm. 2, pp. 313-319

  2. Different Risk Profiles for Progression of Nonproliferative Diabetic Retinopathy: A 2-Year Study

    Ophthalmology and Therapy, Vol. 12, Núm. 1, pp. 485-500

  3. Retinal neurodegeneration in eyes with NPDR risk phenotypes: A two-year longitudinal study

    Acta Ophthalmologica

2022

  1. Association between Neurodegeneration and Macular Perfusion in the Progression of Diabetic Retinopathy: A 3-Year Longitudinal Study

    Ophthalmologica, Vol. 245, Núm. 4, pp. 335-341

  2. Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy

    Ophthalmology and Therapy, Vol. 11, Núm. 1, pp. 333-345

  3. Swept-source OCTA quantification of capillary closure predicts ETDRS severity staging of NPDR

    British Journal of Ophthalmology, Vol. 106, Núm. 5, pp. 712-718

2021

  1. GRASP1 ubiquitination regulates AMPA receptor surface expression and synaptic activity in cultured hippocampal neurons

    FASEB Journal, Vol. 35, Núm. 8

  2. Microaneurysm turnover in mild non-proliferative diabetic retinopathy is associated with progression and development of vision-threatening complications: A 5-year longitudinal study

    Journal of Clinical Medicine, Vol. 10, Núm. 10

  3. Microperimetry and mfERG as functional measurements in diabetic macular oedema undergoing intravitreal ranibizumab treatment

    Eye (Basingstoke), Vol. 35, Núm. 5, pp. 1384-1392

  4. Optical coherence tomography angiography metrics monitor severity progression of diabetic retinopathy—3-year longitudinal study

    Journal of Clinical Medicine, Vol. 10, Núm. 11

  5. Retinal Neurodegeneration in Different Risk Phenotypes of Diabetic Retinal Disease

    Frontiers in Neuroscience, Vol. 15

  6. Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease

    Ophthalmic Research, Vol. 64, Núm. 6, pp. 871-887

2020

  1. Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity

    Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e801-e806

  2. Characterization of disease progression in the initial stages of retinopathy in type 2 diabetes: A 2-year longitudinal study

    Investigative Ophthalmology and Visual Science, Vol. 61, Núm. 3

  3. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?

    Journal of Chemotherapy, pp. 1-13

  4. OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Identification of Choroidal Neovascularization Activity by Location and Quantification of Abnormal Fluid Under Anti-Vascular Endothelial Growth Factor Therapy

    Retina (Philadelphia, Pa.), Vol. 40, Núm. 5, pp. 881-890

2019

  1. Region-specific control of microglia by adenosine A 2A receptors: uncoupling anxiety and associated cognitive deficits in female rats

    GLIA, Vol. 67, Núm. 1, pp. 182-192

  2. Characterization of Initial Stages of Diabetic Macular Edema

    Ophthalmic Research, Vol. 62, Núm. 4, pp. 203-210

  3. Measurements of retinal fluid by optical coherence tomography leakage in diabetic macular edema: A biomarker of visual acuity response to treatment

    Retina, Vol. 39, Núm. 1, pp. 52-60

  4. Multimodal imaging of the initial stages of diabetic retinopathy: Different disease pathways in different patients

    Diabetes, Vol. 68, Núm. 3, pp. 648-653